DermTech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2016
Net Income	-100.89	-116.68	-78.34	-36.48	-20.13	-10	-0
Depreciation & Amortization	5.85	4.46	2.3	0.49	0.09	0.08	0
Share-Based Compensation	18.57	18.93	13.28	4.97	1.3	0.91	0
Other Operating Activities	-0.5	-1.97	0.66	2.34	0.95	1.41	0
Operating Cash Flow	-76.98	-95.26	-62.11	-28.68	-17.79	-7.61	0
Capital Expenditures	-0.9	-3.31	-2.72	-1.83	-0.21	-0.01	0
Change in Investments	30.77	-1.01	-9.79	-39.51	0	0	0
Investing Cash Flow	29.86	-4.32	-12.51	-41.34	-0.21	-0.01	0
Share Issuance / Repurchase	6.19	1.05	230.45	44.31	20.74	0.01	0
Debt Issued / Paid	-0.11	-0.14	-0.17	-0.01	2.08	6.59	-0.01
Other Financing Activities	-	-	-	34.6	5.8	4.54	0.02
Financing Cash Flow	6.08	0.92	230.28	78.9	28.62	11.13	0.01
Net Cash Flow	-41.04	-98.66	155.66	8.87	10.62	3.51	0.01
Free Cash Flow	-77.88	-98.57	-64.83	-30.52	-18	-7.62	0
Free Cash Flow Margin	-509.16%	-678.92%	-547.61%	-518.57%	-535.11%	-311.92%	-
Free Cash Flow Per Share	-2.39	-3.28	-2.24	-1.80	-2.57	-1.73	0.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).